TARGETING MYC/MYCN BY INHIBITION OF CHECKPOINT KINASE 1 (CHK1) SENSITIZES PAEDIATRIC GLIOBLASTOMA (PGBM) CELLS TO TEMOZOLOMIDE
journal contribution
posted on 2024-04-29, 01:49authored byMeera Nandhabalan, Lynn Bjerke, Mara Vinci, Anna Burford, Wendy Ingram, Alan Mackay, Andre von Bueren, Michael Baudis, Paul Clarke, Ian CollinsIan Collins, Paul Workman, Chris Jones
TARGETING MYC/MYCN BY INHIBITION OF CHECKPOINT KINASE 1 (CHK1) SENSITIZES PAEDIATRIC GLIOBLASTOMA (PGBM) CELLS TO TEMOZOLOMIDE